In this study, we will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. We hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.
Who can participate
Age range15 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Pharmacies
* Registered with the Pharmacy and Poisons Board (PPB)
* Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff
* Must have a private room where HIV testing and PrEP/PEP counseling can occur
* \>3 km from other study pharmacies
* Willing to participate in research activities, including 2-day training for pharmacy providers
* Willing to share pharmacy records with us
* Sells HIVST kits that are WHO certified.
Pharmacists/remote nurses
* ≥ 18 years old
* Licensed pharmacist, pharmaceutical technologist, or nurse
* Willing to provide PrEP and PEP services, including HIV testing and associated counseling services
* Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing
* Able and willing to provide informed consent
Clients
* ≥ 15 years old
* Interested in being screened for PrEP or PEP
* Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety
* Able and willing to provide informed consent
Exclusion Criteria:
Clients
* Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information
* Currently enrolled in any other HIV vaccine or prevention trial
* Have a condition that would preclude provision of informed …